LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1235 | 1049 | 4070 | 0.2577 | -0.0907 |
| MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1235 | 831 | 4126 | 0.2014 | -0.2038 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1235 | 1192 | 3974 | 0.2999 | -0.0210 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1235 | 1074 | 4070 | 0.2639 | -0.0782 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1235 | 1116 | 4126 | 0.2705 | -0.0567 |
| MCF7 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1235 | 2903 | 4119 | 0.7048 | 0.6352 |
| MCF7 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1235 | 2660 | 4356 | 0.6106 | 0.5248 |
| MCF7 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1235 | 2301 | 4326 | 0.5319 | 0.4105 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1235 | 1079 | 3974 | 0.2715 | -0.0772 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1235 | 1017 | 4070 | 0.2499 | -0.1069 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1235 | 872 | 4126 | 0.2113 | -0.1814 |
| MCF7 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1235 | 1295 | 4119 | 0.3144 | 0.0275 |
| MCF7 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1235 | 1226 | 4356 | 0.2814 | -0.0042 |
| MCF7 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1235 | 1300 | 4326 | 0.3005 | 0.0286 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1235 | 922 | 3974 | 0.2320 | -0.1594 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1235 | 994 | 4070 | 0.2442 | -0.1187 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1235 | 1000 | 4126 | 0.2423 | -0.1144 |
| MCF7 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1235 | 931 | 4119 | 0.2260 | -0.1503 |
| MCF7 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1235 | 913 | 4356 | 0.2096 | -0.1532 |
| MCF7 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1235 | 876 | 4326 | 0.2025 | -0.1731 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1235 | 1208 | 3974 | 0.3040 | -0.0132 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1235 | 959 | 4070 | 0.2356 | -0.1369 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1235 | 1030 | 4126 | 0.2496 | -0.0992 |
| MCF7 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1235 | 1004 | 4119 | 0.2437 | -0.1125 |
| MCF7 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1235 | 918 | 4356 | 0.2107 | -0.1507 |